Yongping Gu

471 total citations
12 papers, 367 citations indexed

About

Yongping Gu is a scholar working on Cancer Research, Immunology and Molecular Biology. According to data from OpenAlex, Yongping Gu has authored 12 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Yongping Gu's work include Effects of Radiation Exposure (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). Yongping Gu is often cited by papers focused on Effects of Radiation Exposure (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). Yongping Gu collaborates with scholars based in China and United States. Yongping Gu's co-authors include Xueguang Zhang, Fang Xie, Yongjing Chen, Zemin Wang, Liang Dong, Lingling Guo, Huilin Yang, Shigang Li, Liang Chen and Zheng‐Hong Qin and has published in prestigious journals such as Oncotarget, Journal of Neuroimmunology and Human Mutation.

In The Last Decade

Yongping Gu

12 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongping Gu China 10 151 137 124 92 88 12 367
Hideki Yoshikawa Japan 7 98 0.6× 149 1.1× 36 0.3× 180 2.0× 67 0.8× 14 377
Julie Chesneau France 11 155 1.0× 192 1.4× 31 0.3× 109 1.2× 66 0.8× 16 347
Irena Klima Switzerland 11 157 1.0× 233 1.7× 37 0.3× 114 1.2× 125 1.4× 17 485
M. Padrines France 7 232 1.5× 274 2.0× 27 0.2× 47 0.5× 64 0.7× 9 417
Hiroyuki Goda Japan 13 146 1.0× 206 1.5× 58 0.5× 45 0.5× 81 0.9× 30 381
Koji Ezumi Japan 7 323 2.1× 269 2.0× 53 0.4× 87 0.9× 118 1.3× 9 566
D. Matthew Gianferante United States 4 103 0.7× 302 2.2× 54 0.4× 172 1.9× 203 2.3× 8 513
Wangzhao Song Netherlands 11 102 0.7× 242 1.8× 23 0.2× 125 1.4× 98 1.1× 15 415
Akihiro Imada Japan 5 86 0.6× 151 1.1× 141 1.1× 130 1.4× 42 0.5× 7 399
Hiu Fung Yuen Singapore 8 123 0.8× 256 1.9× 53 0.4× 52 0.6× 86 1.0× 9 350

Countries citing papers authored by Yongping Gu

Since Specialization
Citations

This map shows the geographic impact of Yongping Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Gu more than expected).

Fields of papers citing papers by Yongping Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Gu. The network helps show where Yongping Gu may publish in the future.

Co-authorship network of co-authors of Yongping Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Gu. A scholar is included among the top collaborators of Yongping Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Gu. Yongping Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Li, Gen, Anqing Wu, Dandan Qi, et al.. (2016). Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapy. Oncotarget. 7(46). 75685–75697. 6 indexed citations
2.
Qiu, Chen, Shu Wu, Xiaochun Xia, et al.. (2015). Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage. Journal of Radiation Research. 56(2). 278–286. 20 indexed citations
3.
Wang, Qin, Cheng Wang, Longjiang Xu, et al.. (2015). PD-L1 mediated the differentiation of tumor-infiltrating CD19+B lymphocytes and T cells in Invasive breast cancer. OncoImmunology. 5(2). e1075112–e1075112. 68 indexed citations
4.
Qiu, Chen, Xiaochun Xia, Shu Wu, et al.. (2014). Apoptosis, necrosis, and autophagy in mouse intestinal damage after 15‐Gy whole body irradiation. Cell Biochemistry and Function. 32(8). 647–656. 9 indexed citations
5.
Chen, Chao, Huilin Yang, Liang Chen, et al.. (2013). High expression of survivin in sacral chordoma. Medical Oncology. 30(2). 529–529. 18 indexed citations
7.
Wang, Weipeng, Jing Sun, Fang Li, et al.. (2011). A frequent somatic mutation in CD274 3′-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding. Human Mutation. 33(3). 480–484. 81 indexed citations
8.
Chen, Liang, Huilin Yang, Jian Lü, et al.. (2010). Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma. Journal of Neuro-Oncology. 101(3). 357–363. 35 indexed citations
9.
Xie, Fang, Qin Wang, Yongjing Chen, et al.. (2010). Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study. Pathology - Research and Practice. 206(11). 735–739. 24 indexed citations
10.
Xie, Fang, Qin Shi, Qin Wang, et al.. (2010). CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma. Journal of Neuroimmunology. 222(1-2). 62–69. 21 indexed citations
11.
Guo, Lingling, et al.. (2009). Selection of optimal sites for TGFB1 gene silencing by chitosan–TPP nanoparticle-mediated delivery of shRNA. Cancer Genetics and Cytogenetics. 190(1). 8–14. 41 indexed citations
12.
Wang, Caiying, et al.. (2007). A novel cultured tissue model of rat aorta: VSMC proliferation mechanism in relationship to atherosclerosis. Experimental and Molecular Pathology. 83(3). 453–458. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026